Technology
Health
Pharmaceutical

Sutro Biopharma

$10.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.48 (-4.21%) Today
-$0.48 (-4.21%) Today

Why Robinhood?

You can buy or sell STRO and other stocks, options, ETFs, and crypto commission-free!

About

Sutro Biopharma Inc. engages in the drug discovery, development, and manufacturing of pharmaceutical products. Its products technologies include XpressCF; anti-body drug conjugates; bispecifics and engineered antibodies; and cGMP facility. Read More The company was founded in June 2003 and is headquartered in South San Francisco, CA.

Employees
Headquarters
South San Francisco, California
Founded
2003
Market Cap
260.24M
Price-Earnings Ratio
Dividend Yield
Average Volume
71.28K
High Today
$10.91
Low Today
$10.91
Open Price
$10.91
Volume
1.41K
52 Week High
$15.90
52 Week Low
$8.50

Collections

Technology
Health
Pharmaceutical
Manufacturing
2018 IPO
US
North America

News

PR NewswireMar 5

Sutro Biopharma to Present at the Cowen and Company 39th Annual Health Care Conference

SOUTH SAN FRANCISCO, Calif., March 5, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11 at 2:50 p.m. ET at the Marriott Copley Place in Boston. A live webcast of the presentation will be accessible through the Events and Presentations page of the Investor Relations section of the company's website at www.sutrobio.com. A replay of the webcast will be...

3

Earnings

-$21.26
-$14.23
-$7.19
-$0.16
Q3 2018
Q4 2018
Estimated
-$0.63 per share
Actual
Expected Today, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.